Holen Sie sich die Stockscreener-App
74.73
0.82%
0.61
Vorhandelsmarkt:
74.85
0.12
+0.16%
Schlusskurs vom Vortag:
$74.12
Offen:
$74.82
24-Stunden-Volumen:
13.45M
Relative Volume:
1.04
Marktkapitalisierung:
$110.83B
Einnahmen:
$20.08B
Nettoeinkommen (Verlust:
$2.89B
KGV:
38.54
EPS:
1.9391
Netto-Cashflow:
$3.82B
1W Leistung:
-2.02%
1M Leistung:
-20.62%
6M Leistung:
-27.09%
1J Leistung:
-29.59%
1-Tages-Spanne:
$74.43
$76.37
1-Wochen-Bereich:
$72.69
$76.37
52-Wochen-Spanne:
$72.69
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Pulmonary Artery Catheter Market Size to Reach USD 1.97 Billion by 2035 Caused by the Surging Critical Care Procedures Globally - GlobeNewswire Inc.
Boston Scientific Corporation (NYSE:BSX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Peering Into Boston Scientific Corp's Recent Short Interest - Benzinga
Vanguard Group Inc. Buys 1,115,337 Shares of Boston Scientific Corporation $BSX - MarketBeat
Capital Planning Advisors LLC Invests $1.45 Million in Boston Scientific Corporation $BSX - MarketBeat
Assetmark Inc. Sells 82,501 Shares of Boston Scientific Corporation $BSX - MarketBeat
State of New Jersey Common Pension Fund D Purchases 21,386 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation (BSX) Maintains Analyst Ratings Amid Target Adjustments - Finviz
Aberdeen Group plc Has $257.62 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
ABN Amro Investment Solutions Has $54.76 Million Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Stock Slide Tests Support As Outlook And Value Diverge - Yahoo Finance
Reassessing Boston Scientific (BSX) After A 30% Pullback In The Share Price - Yahoo Finance
Can Boston Scientific Corporation stock sustain margin levelsIPO Watch & Risk Controlled Daily Trade Plans - mfd.ru
Does Boston Scientific Corporation stock benefit from AI growthWeekly Trade Analysis & Fast Entry Momentum Trade Alerts - mfd.ru
Atria Investments Inc Purchases 35,788 Shares of Boston Scientific Corporation $BSX - MarketBeat
BSX Posts Q4 Earnings: Should You Buy, Sell or Hold the Stock? - Finviz
Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference - Finviz
Boston Scientific Corp (NYSE:BSX) Emerges as a Prime GARP Candidate - ChartMill
Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference – Company Announcement - Financial Times
Public Sector Pension Investment Board Purchases 903,448 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Illinois Municipal Retirement Fund - MarketBeat
Will Boston Scientific Corporation stock hit new highs in YEAR2025 Trade Ideas & Long-Term Growth Stock Strategies - mfd.ru
Is Boston Scientific Corporation still a buy after recent gainsOptions Play & Momentum Based Trading Signals - mfd.ru
Boston Sci’s Farapulse better than thermal ablation at 4 years - bioworld.com
The Top 5 Analyst Questions From Boston Scientific's Q4 Earnings Call - Finviz
Impax Asset Management Group plc Boosts Holdings in Boston Scientific Corporation $BSX - MarketBeat
Aug EndMonth: Can Boston Scientific Corporation sustain its profitabilityMarket Trend Summary & Precise Trade Entry Recommendations - baoquankhu1.vn
The Top 5 Analyst Questions From Boston Scientific’s Q4 Earnings Call - Yahoo Finance
Boston Scientific Board Change Puts Growth And Risk Oversight In Focus - Yahoo Finance
Boston Scientific (BSX) stock price edges up after selloff; Farapulse data and March 28 CHAMPION-AF readout in focus - TechStock²
Boston Scientific Corp (BSX) Stock Price, Trades & News - GuruFocus
Boston Scientific (NYSE:BSX) Reaches New 12-Month LowTime to Sell? - MarketBeat
Levi & Korsinsky Investigates Possible Securities Fraud by Boston Scientific Corporation (BSX) - marketscreener.com
Boston Scientific Farapulse PFA outperforms thermal ablation in study - massdevice.com
Boston Scientific (BSX) Analyst Ratings and Price Targets Update - GuruFocus
Boston Scientific stock price slips again: BSX extends slide as heart-rhythm worries linger - TechStock²
Fraud Investigation Opened: Levi & Korsinsky Investigates Boston Scientific Corporation (BSX) on Behalf of Shareholders - marketscreener.com
Truist Cuts Boston Scientific Corporation (BSX) Price Target but Maintains Buy After Earnings Pullback - Finviz
Why Analysts See Boston Scientific (BSX) Differently After Target Cuts And A Fair Value Reset - Yahoo Finance
Boston Scientific (NYSE:BSX) Cut to "Hold" at Wall Street Zen - MarketBeat
Boston Scientific stock price slips again after earnings shock as BSX investors eye heart-rhythm sales - TechStock²
Boston Scientific’s Worst Day in 25 Years Surprised Analysts - Bloomberg.com
Boston Scientific to Report Q4 Earnings with Expected Growth - Intellectia AI
Securities Fraud Investigation Into Boston Scientific Corporation (BSX) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Chartmill
Bernstein SocGen lowers Boston Scientific stock price target on EP miss - Investing.com
RBC Capital lowers Boston Scientific stock price target to $115 on 2026 guidance - Investing.com
Boston Scientific stock holds Outperform rating at Evercore despite EP miss - Investing.com
Boston Scientific price target lowered to $110 from $125 at Stifel - Yahoo Finance
Boston Scientific’s (BSX) Earnings Implosion Sparks Bullish Options Trade - TipRanks
Boston Scientific (BSX): Analyst Ratings Update and Target Price Changes | BSX Stock News - GuruFocus
Boston Scientific (BSX): Canaccord Genuity Adjusts Price Target, Maintains Buy Rating | BSX Stock News - GuruFocus
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):